This conference, organized by Nencki Institute of Experimental Biology PAS, will address the opportunities and barriers in the creation of new University based, hi-tech companies with a focus on life science innovations.
On the one hand Poland benefits from a substantial influx of European Funds, which in part helped to establish multiple seed and early stage VC funds. On the other hand, the tax and legal environment is still sub-optimal and only a minority of projects emerging from Polish universities and research institutes offer high commercial value.
Despite the general lack of entrepreneurial culture and incentives for researchers – several high-tech Polish Life Science start-ups are emerging and becoming internationally competitive. The conference will feature case studies and success stories relayed both by Polish and international entrepreneurs and scientists. Best practice examples from abroad and practical solutions for the Polish legal and financial environment will be presented along with possible solutions to eliminate the main bottlenecks and limitations in the Polish system.
Along with the successful researcher / entrepreneur perspective the conference will provide a Venture Capital / Investor view on success factors in securing investment and building company value. The conference will feature presentations and panel discussions with international experts from USA, Singapore, Germany, Israel, UK, Belgium, Austria.
Receive the Funding Newswire each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening. 
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.